Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Bras Pneumol ; 50(3): e20240156, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39166593

RESUMO

Asbestos was largely used in Brazil. It is a mineral that induces pleural and pulmonary fibrosis, and it is a potent carcinogen. Our objective was to develop recommendations for the performance of adequate imaging tests for screening asbestos-related diseases. We searched peer-reviewed publications, national and international technical documents, and specialists' opinions on the theme. Based on that, the major recommendations are: Individuals exposed to asbestos at the workplace for ≥ 1 year or those with a history of environmental exposure for at least 5 years, all of those with a latency period > 20 years from the date of initial exposure, should initially undego HRCT of the chest for investigation. Individuals with pleural disease and/or asbestosis should be considered for regular lung cancer monitoring. Risk calculators should be adopted for lung cancer screening, with a risk estimate of 1.5%.


Assuntos
Amianto , Asbestose , Neoplasias Pulmonares , Exposição Ocupacional , Humanos , Brasil , Asbestose/diagnóstico por imagem , Asbestose/diagnóstico , Amianto/efeitos adversos , Exposição Ocupacional/efeitos adversos , Neoplasias Pulmonares/diagnóstico por imagem , Sociedades Médicas , Tomografia Computadorizada por Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA